S'abonner

Nuclear Cardiology Practices and Radiation Exposure in the Oceania Region: Results From the IAEA Nuclear Cardiology Protocols Study (INCAPS) - 18/04/17

Doi : 10.1016/j.hlc.2016.05.112 
Sinjini Biswas, MBBS, BMedSc a, , Nathan Better, MBBS, FRACP a, Thomas N.B. Pascual, MD b, Mathew Mercuri, PhD c, João V. Vitola, MD, PhD d, Ganesan Karthikeyan, MBBS, MD, DM, MSc e, James Westcott, BAppSc(MedRad) a, Erick Alexánderson, MD f, Adel H. Allam, MD g, Mouaz H. Al-Mallah, MD, MS h, Henry Hee-Seung Bom, MD, PhD i, Salah E. Bouyoucef, MD j, Albert Flotats, MD k, Scott Jerome, DO l, m, Philip A. Kaufman, MD n, Vikram Lele, MD o, Osnat Luxenburg, MD, MPH, MBA p, q, John J. Mahmarian, MD r, Leslee J. Shaw, PhD s, S. Richard Underwood, DM, FRCP t, u, Madan Rehani, PhD v, w, Ravi Kashyap, MD b, Maurizio Dondi, MD b, Diana Paez, MD b, Andrew J. Einstein, MD, PhD c, x

for the INCAPS Investigators Group

a Department of Cardiology and Department of Nuclear Medicine, Royal Melbourne Hospital, Melbourne, Vic., Australia 
b Section of Nuclear Medicine and Diagnostic Imaging, Division of Human Health International Atomic Energy Agency, Vienna, Austria 
c Division of Cardiology, Department of Medicine, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA 
d Quanta Diagnostico & Terapia, Curitiba, Brazil 
e Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India 
f Departamento de Cardiología Nuclear, Instituto Nacional de Cardiología “Ignacio Chávez”, Mexico, Mexico 
g Cardiology Department, Al Azhar University, Cairo, Egypt 
h Division of Advanced Cardiac Imaging, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia 
i Department of Nuclear Medicine, Chonnam National University Medical School, Gwangju, Korea 
j Centre Hospitalo-Universitaire de Bab El Ouéd, Alger, Algeria 
k Nuclear Medicine Department, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain 
l Intersocietal Accreditation Commission, Ellicott City, Maryland, USA 
m Division of Cardiovascular Medicine, University of Maryland, Baltimore, USA 
n Department of Nuclear Medicine and Cardiac Imaging, University Hospital Zurich, Zurich, Switzerland 
o Department of Nuclear Medicine and PET-CT, Jaslok Hospital and Research Centre, Mumbai, India 
p Medical Technology and Infrastructure Administration, Ministry of Health, Jerusalem, Israel 
q Israeli Center for Technology Assessment in Health Care, Gertner Institute for Epidemiology and Health Policy Research, Tel Hashomer, Israel 
r Department of Cardiology, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA 
s Division of Cardiology, Department of Medicine, and Emory Clinical Cardiovascular Research Institute, Emory University School of Medicine, Atlanta, Georgia, USA 
t National Heart and Lung Institute, Imperial College London, London, England 
u Department of Nuclear Medicine, Royal Brompton and Harefield Hospitals, London, England 
v Radiation Protection of Patients Unit, International Atomic Energy Agency, Vienna, Austria 
w Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA 
x Department of Radiology, Columbia University Medical Center and New York-Presbyterian Hospital, New York, NY, USA 

Corresponding author at: Department of Cardiology & Nuclear Medicine, Royal Melbourne Hospital, Parkville, Victoria 3052, Tel.: +61 401 067 058

Résumé

Background

There is concern about radiation exposure with radionuclide myocardial perfusion imaging (MPI). This sub-study of the International Atomic Energy Agency (IAEA) Nuclear Cardiology Protocols Study reports radiation doses from MPI, and use of dose-optimisation protocols in Australia and New Zealand (ANZ), and compares them with data from the rest of the world.

Methods

Data were collected from 7911 MPI studies performed in 308 laboratories worldwide in one week in 2013, including 439 MPI studies from 34 ANZ laboratories. For each laboratory, effective radiation dose (ED) and a quality index (QI) score (out of 8) based on pre-specified “best practices” was determined.

Results

In ANZ patients, ED ranged from 0.9-17.9 milliSievert (mSv). Median ED was similar in ANZ compared with the rest of the world (10.0 (IQR: 6.5-11.7) vs. 10.0 (IQR 6.4-12.6, P=0.15), as were mean QI scores (5.5±0.7 vs. 5.4±1.3, P=0.84). Use of stress-only imaging (17.6% vs. 31.8% of labs, P=0.09) and weight-based dosing of technetium-99m (14.7% vs. 30.3%, P=0.07) was lower in ANZ compared with the rest of the world but this difference was not statistically significant. Median ED was significantly lower in metropolitan versus non-metropolitan laboratories (10.1 mSv vs. 11.6 mSv, P<0.01), although mean QI scores were similar (5.4±0.8 vs. 5.5±0.7, P=0.75).

Conclusion

Across ANZ, there is variability in ED from MPI, and use of radiation safety practices, particularly between metropolitan and non-metropolitan laboratories. Overall, ANZ laboratories have a similar median ED to laboratories in the rest of the world.

Le texte complet de cet article est disponible en PDF.

Keywords : Myocardial perfusion imaging, Radiation exposure

Abbreviations : MPI, IAEA, INCAPS, ANZ, ED, QI, CAD, mSv


Plan


© 2016  Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 26 - N° 1

P. 25-34 - janvier 2017 Retour au numéro
Article précédent Article précédent
  • A Long Term Follow-up Study of Carriers of Hypertrophic Cardiomyopathy Mutations
  • Don R McTaggart, Kathryn J Ogden, Jessica A Marathe
| Article suivant Article suivant
  • Comparison of Safety and Effectiveness Between Right Versus Left Radial Arterial Access in Primary Percutaneous Coronary Intervention for Acute ST Segment Elevation Myocardial Infarction
  • Mahmoud Farouk Elmahdy, Mohamed ElMaghawry, Mohamed Hassan, Hussien Heshmat Kassem, Karim Said, Amr AbdelAziz Elfaramawy

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.